none

UBER CO-FOUNDER INVESTS IN PHARMECUTICAL DISRUPTION

01-09-2016
by 
in 

 Oscar Salazar, co-founder of Uber, and Walter Jin, founder of Carlyle Healthcare Group, have invested in Series-A funding round and joined the board of RxAdvance, a full service Pharmacy Benefits Management company.

Oscar Salazar is a co-founder of Pager, an innovative on-demand healthcare service that utilizes a mobile patient engagement platform to connect patients with the right type of care. Prior to Pager, Oscar was a founding partner and Chief Technology Officer of Uber.

“Our goal is to leverage disruptive technology and world-class design to reinvent healthcare and deliver cost savings and efficiencies," said Oscar and Walter.

“We are proud to join the RxAdvance board, as its accountable drug benefit management practice and risk-sharing business models are timely in this antiquated industry and are perfectly aligned with the healthcare investments in which we are involved.”

“In the recent years, several successful Silicon Valley entrepreneurs and blue chip companies have entered the healthcare vertical to disrupt and transform, in vain.

This lack of success can be attributed to the absence of substantial business and revenue models, disruptive service offerings, and a proven track record in the complex healthcare eco-system,” says John Sculley, former Apple CEO and Vice Chairman of RxAdvance."

“What impressed me about Ravi and his team at RxAdvance is that they have all the essential components for success - a widely proven and successful revenue model, a solid platform and innovative thinking, a proven track record, and deep healthcare domain expertise capable of disrupting traditional paradigms throughout the care continuum. Through its innovative Collaborative PBM Cloud™, RxAdvance is challenging large incumbent PBMs by disrupting their decades-old business and revenue models, and their risk-sharing models are unheard of in the PBM market.”

There is great synergy between RxAdvance and Pager. Both brands use world class technology and clinical resources to disrupt traditional healthcare delivery practices. Through their partnership, high quality healthcare services will be made more efficient, cost-effective, and convenient.

“We are honored to have two of the leading minds in disruptive technology and business as our investment partners and board members. We at RxAdvance feel that their high-tech experience and guidance will help to transform the $770 billion PBM and associated avoidable drug-impacted medical spend that is long overdue for innovation,” says Ravi Ika, President & CEO of RxAdvance.

Related news & editorials

  1. 17.09.2020
    17.09.2020
    by      In
    A new report from Australia’s national science agency, CSIRO, has revealed the opportunities for key industries to leverage science and technology and help restore economic growth and resilience.
    The COVID-19: Recovery and resilience report highlights the trends and national advantages COVID-19... Read More
  2. 17.09.2020
    17.09.2020
    by      In
    As with many industries, compressed air can be a significant cost if not conserved.
    In many areas of production more than 20% of compressed air energy can be attributed to waste.
    Key Account Manager for SMC Corporation Australia New Zealand  - Dairy Industry, Paul Grantham describes what “... Read More
  3. 17.09.2020
    17.09.2020
    by      In
    A high percentage of health care workers are at risk of contracting airborne diseases such as COVID-19 due to personal protective equipment facemasks not fitting correctly, according to a review of literature carried out by researchers from The University of Western Australia, Perth Children’s... Read More
  4. 17.09.2020
    17.09.2020
    by      In
    Nine out of 10 Australians believe Australia should produce more products locally as a result of the COVID-19 pandemic, according to a consumer research by Roy Morgan.
    The study found 89 per cent of Australians believe manufacturing should be re-shored. Reliance on other countries topped the list... Read More